Cargando…

Predicting future rates of tau accumulation on PET

Clinical trials with anti-tau drugs will need to target individuals at risk of accumulating tau. Our objective was to identify variables available in a research setting that predict future rates of tau PET accumulation separately among individuals who were either cognitively unimpaired or cognitivel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jack, Clifford R, Wiste, Heather J, Weigand, Stephen D, Therneau, Terry M, Lowe, Val J, Knopman, David S, Botha, Hugo, Graff-Radford, Jonathan, Jones, David T, Ferman, Tanis J, Boeve, Bradley F, Kantarci, Kejal, Vemuri, Prashanthi, Mielke, Michelle M, Whitwell, Jennifer, Josephs, Keith, Schwarz, Christopher G, Senjem, Matthew L, Gunter, Jeffrey L, Petersen, Ronald C
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586089/ https://www.ncbi.nlm.nih.gov/pubmed/33094327 http://dx.doi.org/10.1093/brain/awaa248

Ejemplares similares

The bivariate distribution of amyloid-β and tau: relationship with established neurocognitive clinical syndromes
por: Jack, Clifford R, et al.
Publicado: (2019)

Longitudinal tau PET in ageing and Alzheimer’s disease
por: Jack, Clifford R, et al.
Publicado: (2018)

Associations of quantitative susceptibility mapping with Alzheimer’s disease clinical and imaging markers
por: Cogswell, Petrice M., et al.
Publicado: (2020)

Predicting amyloid PET and tau PET stages with plasma biomarkers
por: Jack, Clifford R, et al.
Publicado: (2023)

Selecting software pipelines for change in flortaucipir SUVR: Balancing repeatability and group separation
por: Schwarz, Christopher G., et al.
Publicado: (2021)

Regional cortical perfusion on arterial spin labeling MRI in dementia with Lewy bodies: Associations with clinical severity, glucose metabolism and tau PET
por: Nedelska, Zuzana, et al.
Publicado: (2018)

Relationships between β-amyloid and tau in an elderly population: An accelerated failure time model
por: Therneau, Terry M., et al.
Publicado: (2021)

Long-term associations between amyloid positron emission tomography, sex, apolipoprotein E and incident dementia and mortality among individuals without dementia: hazard ratios and absolute risk
por: Jack, Clifford R., et al.
Publicado: (2022)

AV‐1451 tau and β‐amyloid positron emission tomography imaging in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2016)

Longitudinal Tau Positron Emission Tomography in Dementia with Lewy Bodies
por: Chen, Qin, et al.
Publicado: (2022)

Prevalence of Biologically vs Clinically Defined Alzheimer Spectrum Entities Using the National Institute on Aging–Alzheimer’s Association Research Framework
por: Jack, Clifford R., et al.
Publicado: (2019)

Age and sex specific prevalences of cerebral β-amyloidosis, tauopathy and neurodegeneration among clinically normal individuals aged 50-95 years: a cross-sectional study
por: Jack, Clifford R., et al.
Publicado: (2017)

Rates of transition between amyloid and neurodegeneration biomarker states and to dementia among non-demented individuals: a population-based cohort study
por: Jack, Clifford R., et al.
Publicado: (2015)

Rates of β-amyloid accumulation are independent of hippocampal neurodegeneration
por: Jack, Clifford R., et al.
Publicado: (2014)

White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition
por: Raghavan, Sheelakumari, et al.
Publicado: (2022)

Effects of de-facing software mri_reface on utility of imaging biomarkers used in Alzheimer’s disease research
por: Schwarz, Christopher G., et al.
Publicado: (2023)

MRI and flortaucipir relationships in Alzheimer's phenotypes are heterogeneous
por: Josephs, Keith A., et al.
Publicado: (2020)

Association of Longitudinal β-Amyloid Accumulation Determined by Positron Emission Tomography With Clinical and Cognitive Decline in Adults With Probable Lewy Body Dementia
por: Nedelska, Zuzana, et al.
Publicado: (2019)

Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings
por: Jack, Clifford R., et al.
Publicado: (2015)

Association of Apolipoprotein E ɛ4, Educational Level, and Sex With Tau Deposition and Tau-Mediated Metabolic Dysfunction in Older Adults
por: Ramanan, Vijay K, et al.
Publicado: (2019)

Face recognition from research brain PET: An unexpected PET problem
por: Schwarz, Christopher G., et al.
Publicado: (2022)

β-Amyloid PET and neuropathology in dementia with Lewy bodies
por: Kantarci, Kejal, et al.
Publicado: (2020)

NIA‐AA Alzheimer's Disease Framework: Clinical Characterization of Stages
por: Petersen, Ronald C., et al.
Publicado: (2021)

Development of a cerebrovascular magnetic resonance imaging biomarker for cognitive aging
por: Vemuri, Prashanthi, et al.
Publicado: (2018)

(18)F‐AV‐1451 uptake differs between dementia with lewy bodies and posterior cortical atrophy
por: Nedelska, Zuzana, et al.
Publicado: (2019)

(18)F-fluorodeoxyglucose positron emission tomography in dementia with Lewy bodies
por: Graff-Radford, Jonathan, et al.
Publicado: (2020)

FDG PET metabolic signatures distinguishing prodromal DLB and prodromal AD
por: Kantarci, Kejal, et al.
Publicado: (2021)

Dementia with Lewy bodies: association of Alzheimer pathology with functional connectivity networks
por: Schumacher, Julia, et al.
Publicado: (2021)

β-Amyloid PET and (123)I-FP-CIT SPECT in Mild Cognitive Impairment at Risk for Lewy Body Dementia
por: Chen, Qin, et al.
Publicado: (2021)

White Matter Degeneration Pathways Associated With Tau Deposition in Alzheimer Disease
por: Tian, Jianqiao, et al.
Publicado: (2023)

A Comparison of Partial Volume Correction Techniques for Measuring Change in Serial Amyloid PET SUVR
por: Schwarz, Christopher G., et al.
Publicado: (2019)

Amyloid- and tau-PET imaging in a familial prion kindred
por: Jones, David T., et al.
Publicado: (2018)

Longitudinal atrophy in prodromal dementia with Lewy bodies points to cholinergic degeneration
por: Kantarci, Kejal, et al.
Publicado: (2022)

Evidence against a temporal association between cerebrovascular disease and Alzheimer’s disease imaging biomarkers
por: Cogswell, Petrice M., et al.
Publicado: (2023)

Optimum Differentiation of Frontotemporal Lobar Degeneration from Alzheimer Disease Achieved with Cross‐Sectional Tau Positron Emission Tomography
por: Josephs, Keith A., et al.
Publicado: (2022)

Cross–scanner harmonization methods for structural MRI may need further work: A comparison study
por: Gebre, Robel K., et al.
Publicado: (2023)

(18)F-FDG PET-CT pattern in idiopathic normal pressure hydrocephalus
por: Townley, Ryan A., et al.
Publicado: (2018)

Posterior cortical atrophy phenotypic heterogeneity revealed by decoding (18)F-FDG-PET
por: Townley, Ryan A, et al.
Publicado: (2021)

A computational model of neurodegeneration in Alzheimer’s disease
por: Jones, D., et al.
Publicado: (2022)

Considerations for Performing Level-2 Centiloid Transformations for Amyloid PET SUVR values
por: Schwarz, Christopher G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gvmoa7fkb5jhm0ldlq1qs3vssc